The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), this week announced that the fourth iteration of the Adaptive COVID-19 Treatment […]
“Systemic racism is as real as any disease,” says Rebecca Marklund in a recent PhRMA blog. “Diversifying clinical trials is a critical path to change and PhRMA, and its […]
For decades, the power of the placebo effect was thought to lie in patients’ belief that they were—or at least, could be—receiving a pharmacologically active treatment. A new study by […]
The COVID-19 pandemic proved the clinical trial industry can rally quickly to develop vaccines in record time. It also may have proven that remote monitoring of study sites is here […]
Even with access to a clinical trial, cancer patients living in the poorest neighborhoods in America have a nearly 30% greater chance of dying from their disease compared to the […]